Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2016
Reply to T.J. Kruser et al
Olivier L Chinot, Martin J B Taphoorn, Carlos Bais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
Martin J B Taphoorn, Roger Henriksson, Andrew Bottomley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 26, 2021
Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique
Emily Durie, Emma Nicholson, Chloe Anthias, et al.
Journal of Neuro-Oncology
|
April 12, 2018
Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience
Niamh Coleman, Vasiliki Michalarea, Scheryll Alken, et al.
Plos One
|
May 28, 2016
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
Nicholas Brown, Catherine McBain, Stephen Nash, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 25, 2006
Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study
Barry L Pizer, Claire L Weston, Kathryn J Robinson, et al.
The New England Journal of Medicine
|
February 21, 2014
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
Olivier L Chinot, Wolfgang Wick, Warren Mason, et al.
Neuro-Oncology
|
October 20, 2017
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial
Gabriele Calaminus, Didier Frappaz, Rolf Dieter Kortmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trial
Francesco Sanvito, Catalina Raymond, Donatello Telesca, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 6, 2004
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma
Roger E Taylor, Clifford C Bailey, Kathryn J Robinson, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 18, 2016
Reply to T.J. Kruser et al
Olivier L Chinot, Martin J B Taphoorn, Carlos Bais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
Martin J B Taphoorn, Roger Henriksson, Andrew Bottomley, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 26, 2021
Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique
Emily Durie, Emma Nicholson, Chloe Anthias, et al.
Journal of Neuro-Oncology
|
April 12, 2018
Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience
Niamh Coleman, Vasiliki Michalarea, Scheryll Alken, et al.
Plos One
|
May 28, 2016
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
Nicholas Brown, Catherine McBain, Stephen Nash, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 25, 2006
Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study
Barry L Pizer, Claire L Weston, Kathryn J Robinson, et al.
The New England Journal of Medicine
|
February 21, 2014
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
Olivier L Chinot, Wolfgang Wick, Warren Mason, et al.
Neuro-Oncology
|
October 20, 2017
Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial
Gabriele Calaminus, Didier Frappaz, Rolf Dieter Kortmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2026
Framework for statistical parametric mapping of the interactions between glioblastoma location, treatment, prognostic variables, and survival using a phase III trial
Francesco Sanvito, Catalina Raymond, Donatello Telesca, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 6, 2004
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma
Roger E Taylor, Clifford C Bailey, Kathryn J Robinson, et al.
Page
of 8